Issue navigation
Volume 7, Issue 5, October 2002
Editor's Note
For the oncologist from The Oncologist
The Oncologist, Volume 7, Issue 5, October 2002, Page 389, https://doi.org/10.1634/theoncologist.7-5-389
FDA Commentary
Gleevec™ for the Treatment of Chronic Myelogenous Leukemia: U.S. Food and Drug Administration Regulatory Mechanisms, Accelerated Approval, and Orphan Drug Status
The Oncologist, Volume 7, Issue 5, October 2002, Pages 390–392, https://doi.org/10.1634/theoncologist.7-5-390
U.S. Food and Drug Administration Drug Approval Summaries: Imatinib Mesylate, Mesna Tablets, and Zoledronic Acid
The Oncologist, Volume 7, Issue 5, October 2002, Pages 393–400, https://doi.org/10.1634/theoncologist.7-5-393
Original Paper
Clinical Trial Design for Target-Based Therapy
The Oncologist, Volume 7, Issue 5, October 2002, Pages 401–409, https://doi.org/10.1634/theoncologist.7-5-401
Phase II Trial of Weekly Vinorelbine and Trastuzumab as First-Line Therapy in Patients with HER2+ Metastatic Breast Cancer
The Oncologist, Volume 7, Issue 5, October 2002, Pages 410–417, https://doi.org/10.1634/theoncologist.7-5-410
Efficacy of a Primary Chemotherapy Regimen Combining Vinorelbine, Epirubicin, and Methotrexate (VEM) as Neoadjuvant Treatment in 89 Patients with Operable Breast Cancer
The Oncologist, Volume 7, Issue 5, October 2002, Pages 418–423, https://doi.org/10.1634/theoncologist.7-5-418
5-HT3-Receptor Antagonists for the Treatment of Nausea and Vomiting: A Reappraisal of Their Side-Effect Profile
The Oncologist, Volume 7, Issue 5, October 2002, Pages 424–436, https://doi.org/10.1634/theoncologist.7-5-424
CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer?
The Oncologist, Volume 7, Issue 5, October 2002, Pages 437–443, https://doi.org/10.1634/theoncologist.7-5-437
A Phase I Trial of Weekly Paclitaxel Plus Prolonged Oral Eniluracil/5-Fluorouracil in Patients with Refractory Malignancies
The Oncologist, Volume 7, Issue 5, October 2002, Pages 444–450, https://doi.org/10.1634/theoncologist.7-5-444
Aberrant DNA Methylation in Lung Cancer: Biological and Clinical Implications
The Oncologist, Volume 7, Issue 5, October 2002, Pages 451–457, https://doi.org/10.1634/theoncologist.7-5-451
Combining Radiotherapy with Gene Therapy (From the Bench to the Bedside): A Novel Treatment Strategy for Prostate Cancer
The Oncologist, Volume 7, Issue 5, October 2002, Pages 458–466, https://doi.org/10.1634/theoncologist.7-5-458
Fundamentals of Cancer Medicine
The Molecular Perspective: Cadherin
The Oncologist, Volume 7, Issue 5, October 2002, Pages 467–468, https://doi.org/10.1634/theoncologist.7-5-467
News and Special Report
Capitol Report
The Oncologist, Volume 7, Issue 5, October 2002, Pages 469–470, https://doi.org/10.1634/theoncologist.7-5-469
Reflections
’Tis
The Oncologist, Volume 7, Issue 5, October 2002, Page 471, https://doi.org/10.1634/theoncologist.7-5-471
Photographs
The Oncologist, Volume 7, Issue 5, October 2002, Pages 471–471-a, https://doi.org/10.1634/theoncologist.7-5-471-a
